InvestorsObserver
×
News Home

Analyst Rating: Will Precision BioSciences Inc (DTIL) Stock Beat the Market?

Monday, April 18, 2022 01:52 PM | InvestorsObserver Analysts

Mentioned in this article

Analyst Rating: Will Precision BioSciences Inc (DTIL) Stock Beat the Market?

Analysts who follow Precision BioSciences Inc (DTIL) on average expect it to gain 550.00% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating earns Precision BioSciences Inc an Analyst Ranking of 59, which means it ranks higher than 59 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 4.6
Wall Street analysts are rating DTIL a Strong Buy today. Find out what this means to you and get the rest of the rankings on DTIL!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Precision BioSciences Inc Stock Today?

Precision BioSciences Inc (DTIL) stock is down -6.55% while the S&P 500 is higher by 0.23% as of 1:50 PM on Monday, Apr 18. DTIL is down -$0.18 from the previous closing price of $2.67 on volume of 368,780 shares. Over the past year the S&P 500 is higher by 5.75% while DTIL is down -69.25%. DTIL lost -$0.52 per share the over the last 12 months. Click Here to get the full Stock Report for Precision BioSciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App